Results 81 to 90 of about 260,518 (341)
List Decoding—Random Coding Exponents and Expurgated Exponents [PDF]
IEEE Transactions on Information Theory, 2014 28 pages; submitted to the IEEE Trans.
openaire +4 more sources
FEBS Open Bio, EarlyView.In human monocytic cells THP‐1, a limited uptake of native—not oxidized—LDL/VLDL induced expression of scavenger receptor A and cellular adhesion. Induction was inhibited by lysosomotropic (WR‐1065) and lipophilic (BHT) antioxidants and by siRNAs against ferritinophagy.
Martina Čierna +4 more
wiley +1 more source
On the exponent of distribution of the ternary divisor function [PDF]
, 2013 We show that the exponent of distribution of the ternary divisor function d(3) in arithmetic progressions to prime moduli is at least 1/2 + 1/46, improving results of Friedlander-Iwaniec and Heath-Brown.
'Etienne Fouvry, E. Kowalski, P. Michel
semanticscholar +1 more source
On inverses of APN exponents [PDF]
2012 IEEE International Symposium on Information Theory Proceedings, 2012 In this extended abstract we present results on the inverses modulo 2n − 1 of the known APN exponents. In particular, we describe explicitly the inverses of the Welch and Dobbertin exponents and give the main ideas of their proofs. Further, we observe that the inverse of the Dobbertin exponent defines an APN function on F2n of algebraic degree n+3 ...
Kyureghyan, Gohar, Suder, Valentin
openaire +3 more sources
Development of 4T1 breast cancer mouse model system for preclinical carbonic anhydrase IX studies
FEBS Open Bio, EarlyView.Carbonic anhydrase IX (CAIX) is a well‐recognised therapeutic target and prognostic biomarker in cancer. We developed and characterised a robust murine breast cancer model system that is suitable for CAIX studies in vitro and in vivo—it comprises both CAIX‐positive and CAIX‐negative controls and provides a solid platform for the comprehensive ...
Zane Kalniņa +13 more
wiley +1 more source
Emerging polymeric materials in additive manufacturing for use in biomedical applications
AIMS Bioengineering, 2019 Additive manufacturing is poised to enable the next biomedical revolution, where customized, patient-specific tools, therapies, pharmaceuticals, and even replacement organs are taking strides in the biomedical research and development space.
A. Sydney Gladman +2 more
doaj +1 more source
Analysis of the regulation of undecaprenyl diphosphate dephosphorylation in Escherichia coli
FEBS Open Bio, EarlyView.BacA, PgpB, and YbjG phosphatases are involved in undecaprenyl phosphate (C55P) synthesis in Escherichia coli. We analyzed the lipid contents and the gene expression in the gene‐disruption strains. Undecaprenyl diphosphate (C55PP) level increased in the bacA, ybjG double‐disruption strain, but C55P levels were similar in all strains.
Tomotaka Jitsukawa +2 more
wiley +1 more source
On the attribution of black and brown carbon light absorption using the Ångström exponent
, 2013 . The absorption Angstrom exponent (AAE) of externally mixed black carbon (BCExt), or BC internally mixed with non-absorbing material (BCInt), is often used to determine the contribution of brown carbon (BrC) light absorption at short visible wavelengths.
D. Lack, J. Langridge
semanticscholar +1 more source
A Validated Model to Predict Severe Weight Loss in Amyotrophic Lateral Sclerosis
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Severe weight loss in amyotrophic lateral sclerosis (ALS) is common, multifactorial, and associated with shortened survival. Using longitudinal weight data from over 6000 patients with ALS across three cohorts, we built an accelerated failure time model to predict the risk of future severe (≥ 10%) weight loss using five single‐timepoint ...
David G. Lester +4 more
wiley +1 more source
Real‐World Comparison of High‐Efficacy Versus Non‐High‐Efficacy Therapies in Multiple Sclerosis
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective The choice of the first disease modifying treatment (DMT) in multiple sclerosis (MS) is a topic of great interest, and whether high‐efficacy DMTs should be the first choice remains debated. We compared treatment outcomes (no evidence of disease activity [NEDA] and its components) between treatment‐naïve relapsing–remitting MS (RRMS ...
Sarmad Al‐Araji +9 more
wiley +1 more source